Health Care Utilization
Conditions
Brief summary
Our objective is to determine the effectiveness of varied outreach methods (e.g. standard versus tailored MyChart messaging) to children age 6-17 years old who are due for a WCC visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling and appointment completion.
Interventions
OTHERNo Message
No messages are sent
OTHERStandard message
2 MyChart reminders that child is overdue for well child check visit
OTHERTailored message
2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Sponsors
Children's Hospital Medical Center, Cincinnati
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* age 6-17 years * has not had a well child check in past 365 days * no future well child check visit scheduled * parent preferred language = English or Spanish
Exclusion criteria
* no active MyChart account
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Who Completed Well Child Check Visit | Within 8 weeks of the date of intervention or the date of randomization for the control group | Participants completed well child check visit as determined by presence of a well visit billing code documentation in the electronic health record. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Who Scheduled an Appointment for a Well Child Check Visit. | Within 8 weeks of the date of intervention or the date of randomization for the control group | Participant scheduled a well child check visit as determined by electronic health record documentation. |
| Number of Participants Who Received Their First COVID-19 Vaccination | Within 8 weeks of the date of the intervention or the date of randomization for the control group | Participant receipt of their first COVID-19 vaccination as determined by presence of documentation of vaccine administration in the electronic health record. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| No Message No message sent
No Message: No messages are sent | 315 |
| Standard Message 2 MyChart reminders that child is overdue for well child check visit
Standard message: 2 MyChart reminders that child is overdue for well child check visit | 315 |
| Tailored Message 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age
Tailored message: 2 MyChart reminders that child is overdue for well child check visit with date of last WCC and age | 315 |
| Total | 945 |
Baseline characteristics
| Characteristic | No Message | Standard Message | Tailored Message | Total |
|---|---|---|---|---|
| Age, Customized 12-14y | 33 Participants | 40 Participants | 38 Participants | 111 Participants |
| Age, Customized 15-17y | 49 Participants | 44 Participants | 45 Participants | 138 Participants |
| Age, Customized 6-8y | 137 Participants | 133 Participants | 134 Participants | 404 Participants |
| Age, Customized 9-11y | 96 Participants | 98 Participants | 98 Participants | 292 Participants |
| Race/Ethnicity, Customized American Indian and Alaska Native Non-Hispanic | 0 Participants | 0 Participants | 1 Participants | 1 Participants |
| Race/Ethnicity, Customized Asian Non-Hispanic | 5 Participants | 10 Participants | 4 Participants | 19 Participants |
| Race/Ethnicity, Customized Black or African American Hispanic | 2 Participants | 3 Participants | 1 Participants | 6 Participants |
| Race/Ethnicity, Customized Black or African American Non-Hispanic | 211 Participants | 184 Participants | 195 Participants | 590 Participants |
| Race/Ethnicity, Customized Middle Eastern Non-Hispanic | 0 Participants | 0 Participants | 1 Participants | 1 Participants |
| Race/Ethnicity, Customized Missing Data Hispanic | 5 Participants | 6 Participants | 11 Participants | 22 Participants |
| Race/Ethnicity, Customized Missing Data Non-Hispanic | 1 Participants | 3 Participants | 3 Participants | 7 Participants |
| Race/Ethnicity, Customized Multiracial Hispanic | 1 Participants | 1 Participants | 1 Participants | 3 Participants |
| Race/Ethnicity, Customized Multiracial Non-Hispanic | 15 Participants | 21 Participants | 15 Participants | 51 Participants |
| Race/Ethnicity, Customized Native Hawaiian and Other Pacific Islander Hispanic | 1 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized White Hispanic | 3 Participants | 5 Participants | 10 Participants | 18 Participants |
| Race/Ethnicity, Customized White Non-Hispanic | 71 Participants | 82 Participants | 73 Participants | 226 Participants |
| Sex: Female, Male Female | 174 Participants | 152 Participants | 167 Participants | 493 Participants |
| Sex: Female, Male Male | 141 Participants | 163 Participants | 148 Participants | 452 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 315 | 0 / 315 | 0 / 315 |
| other Total, other adverse events | 0 / 315 | 0 / 315 | 0 / 315 |
| serious Total, serious adverse events | 0 / 315 | 0 / 315 | 0 / 315 |
Outcome results
Primary
Number of Participants Who Completed Well Child Check Visit
Participants completed well child check visit as determined by presence of a well visit billing code documentation in the electronic health record.
Time frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Completed Well Child Check Visit | 40 Participants |
| Standard Message | Number of Participants Who Completed Well Child Check Visit | 76 Participants |
| Tailored Message | Number of Participants Who Completed Well Child Check Visit | 61 Participants |
p-value: 095% CI: [1.38, 2.6]Regression, Logistic
p-value: 0.02395% CI: [1.06, 2.13]Regression, Logistic
p-value: 0.12495% CI: [0.94, 1.66]Regression, Logistic
Secondary
Number of Participants Who Received Their First COVID-19 Vaccination
Participant receipt of their first COVID-19 vaccination as determined by presence of documentation of vaccine administration in the electronic health record.
Time frame: Within 8 weeks of the date of the intervention or the date of randomization for the control group
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Received Their First COVID-19 Vaccination | 3 Participants |
| Standard Message | Number of Participants Who Received Their First COVID-19 Vaccination | 14 Participants |
| Tailored Message | Number of Participants Who Received Their First COVID-19 Vaccination | 4 Participants |
Secondary
Number of Participants Who Scheduled an Appointment for a Well Child Check Visit.
Participant scheduled a well child check visit as determined by electronic health record documentation.
Time frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Scheduled an Appointment for a Well Child Check Visit. | 30 Participants |
| Standard Message | Number of Participants Who Scheduled an Appointment for a Well Child Check Visit. | 58 Participants |
| Tailored Message | Number of Participants Who Scheduled an Appointment for a Well Child Check Visit. | 47 Participants |
p-value: 0.00195% CI: [1.32, 2.84]Regression, Logistic
p-value: 0.0495% CI: [1.02, 2.34]Regression, Logistic
p-value: 0.20295% CI: [0.88, 1.74]Regression, Logistic
Post Hoc
Number of Participants Who Received DTaP Vaccination
Participant receipt of DTaP vaccination as determined by presence of documentation of vaccine administration in the electronic health record.
Time frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Received DTaP Vaccination | 8 Participants |
| Standard Message | Number of Participants Who Received DTaP Vaccination | 6 Participants |
| Tailored Message | Number of Participants Who Received DTaP Vaccination | 6 Participants |
Post Hoc
Number of Participants Who Received HPV Vaccination
Participant receipt of HPV vaccination as determined by presence of documentation of vaccine administration in the electronic health record.
Time frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Received HPV Vaccination | 7 Participants |
| Standard Message | Number of Participants Who Received HPV Vaccination | 13 Participants |
| Tailored Message | Number of Participants Who Received HPV Vaccination | 9 Participants |
Post Hoc
Number of Participants Who Received MCV4 Vaccination
Participant receipt of MCV4 vaccination as determined by presence of documentation of vaccine administration in the electronic health record.
Time frame: Within 8 weeks of the date of intervention or the date of randomization for the control group
Population: Analysis includes all patients eligible to receive this vaccine during the 8-week study period
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Message | Number of Participants Who Received MCV4 Vaccination | 9 Participants |
| Standard Message | Number of Participants Who Received MCV4 Vaccination | 10 Participants |
| Tailored Message | Number of Participants Who Received MCV4 Vaccination | 12 Participants |